EGFR and head and neck squamous cell carcinoma: Aberrant activation of EGFR signaling in HNSCC may be achieved by several mechanisms, including overexpression of EGFR and its ligands, establishing autocrine/paracrine loops, EGFR gene amplification, EGFR mutation/polymorphism and transactivation by other receptor tyrosine kinases (RTKs).